Yüklüyor......
A mass spectrometry-based method to quantify in parallel Tau and amyloid β 1–42 in CSF for the diagnostic of Alzheimer’s Disease
Alzheimer’s disease (AD), the most common form of dementia, afflicts about 50 million people worldwide. Currently, AD diagnosis is primarily based on psychological evaluation and can only be confirmed post-mortem. Reliable and objective biomarkers for prognosis and diagnosis have been sought for sev...
Kaydedildi:
| Yayımlandı: | J Proteome Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5679294/ https://ncbi.nlm.nih.gov/pubmed/28112948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.6b00829 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|